Funded Tech Companies
Omniose
Based in St. Louis, Omniose is venture-backed, with investment from National Institutes of Health.
Company Overview
Company Name
Omniose
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4340 Duncan Ave 202
St. Louis, MT 63110
USA
St. Louis, MT 63110
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Omniose was founded in 2017 based on the pioneering glycoconjugation discoveries of our scientific founders Mario Feldman and Christian Harding through a scientific collaboration that characterized a new class of conjugating enzymes. The research operations were established at BioGenerator Labs in St. Louis and the company was previously known as VaxNewMo. Omniose has been awarded $4.6 million in grants from the US NIAID for use of our platform technology to develop vaccines against Group B Streptococcus, Klebsiella pneumoniae, and Streptococcus pneumoniae.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/11/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Cooke
Chief Scientific Officer
Christian Harding
Co-Founder
Mario Feldman
Co-Founder
Christine Szymanski
Company Investors
- National Institutes of Health
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs